Skip to main content

Advertisement

Log in

Investigation of serum endocan and serglycin levels in obstructive sleep apnea

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Apnea-related hypoxia, hypercapnia, and blood pressure fluctuations cause production of various proinflammatory cytokines and trigger a vicious cycle that results in vascular endothelial damage and systemic inflammation in obstructive sleep apnea (OSA). Endothelial function is frequently impaired in OSA even in the absence of significant cardiac or vascular disorders.

Aims

This study aimed to investigate the serum endocan and serglycin levels in OSA patients.

Methods

This prospective study included 78 consecutive patients who admitted to the sleep laboratory of a tertiary referral center with the complaints of daytime sleepiness, witnessed sleep apnea, and/or snoring and who underwent all-night polysomnography (PSG). After PSG, the patients were divided into four groups in relation with their apnea–hypopnea indexes. The groups were compared for endocan and serglycin levels and their correlations with OSA severity. The correlations with demographic data and PSG findings were also investigated.

Results

The OSA and the control groups had significantly different endocan and serglycin levels (\(p = 0.001\), for both). On univariate logistic regression analysis, it was found that serglycin and endocan levels and BMI were predictors of OSA. Multiple logistic regression analysis showed that endocan and serglycin levels were independent predictors for OSA (\(p = 0.027\) and \(p = 0.003\), respectively).

Conclusions

We have demonstrated that elevated endocan and serglycin levels are predictors for OSA. Furthermore, we have showed for the first time in literature that serglycin is correlated with OSA and is an independent predictor for OSA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Young T, Palta M, Dempsey J et al (2009) Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ 108(5):246–249

    PubMed  PubMed Central  Google Scholar 

  2. Peppard PE, Young T, Barnet JH et al (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–1014. https://doi.org/10.1093/aje/kws342

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lee S, Thomas RJ, Kim H et al (2014) Association between high nocturnal blood pressure and white matter change and its interaction by obstructive sleep apnoea among normotensive adults. J Hypertens 32(10):2005–2012; discussion 2012. https://doi.org/10.1097/hjh.0000000000000290

  4. Kum RO, Baklaci D, Ozcan M et al (2017) Increased risk of cerebral white matter lesions in obstructive sleep apnea syndrome. Sleep Biol Rhythms 15(1):49–55. https://doi.org/10.1007/s41105-016-0079-1

    Article  Google Scholar 

  5. Schulz R, Schmidt D, Blum A et al (2000) Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55(12):1046–1051. https://doi.org/10.1136/thorax.55.12.1046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sarrazin S, Adam E, Lyon M, Depontieu F (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta (BBA) Rev Cancer 1765(1):25–37

    Article  CAS  Google Scholar 

  7. Zhang SM, Zuo L, Zhou Q et al (2012) Expression and distribution of endocan in human tissues. Biotech Histochem 87(3):172–178. https://doi.org/10.3109/10520295.2011.577754

    Article  CAS  PubMed  Google Scholar 

  8. Balamir I, Ates I, Topcuoglu C, Turhan T (2018) Association of endocan, ischemia-modified albumin, and hsCRP levels with endothelial dysfunction in type 2 diabetes mellitus. Angiology 69(7):609–616. https://doi.org/10.1177/0003319717740781

    Article  CAS  PubMed  Google Scholar 

  9. Pusuroglu H, Somuncu U, Bolat I et al (2020) Assessment of the relationship between endocan and obstructive sleep apnea severity. Arch Med Sci 16(1)

  10. Altintas N, Mutlu LC, Akkoyun DC et al (2016) Effect of CPAP on new endothelial dysfunction marker, endocan, in people with obstructive sleep apnea. Angiology 67(4):364–374. https://doi.org/10.1177/0003319715590558

    Article  CAS  PubMed  Google Scholar 

  11. Kolset SO, Tveit H (2008) Serglycin – structure and biology. Cell Mol Life Sci 65:1073–1085

    Article  CAS  PubMed  Google Scholar 

  12. Kolset SO, Pejler G (2011) Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol 187(10):4927–4933. https://doi.org/10.4049/jimmunol.1100806

    Article  CAS  PubMed  Google Scholar 

  13. Niemann CU, Abrink M, Pejler G et al (2007) Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood 109(10):4478–4486. https://doi.org/10.1182/blood-2006-02-001719

    Article  CAS  PubMed  Google Scholar 

  14. Kundi H, Gok M, Topcuoglu C, Ornek E (2017) Association of serglycin levels with isolated coronary artery ectasia. Kardiol Pol 75(10):990–996. https://doi.org/10.5603/KP.a2017.0119

    Article  PubMed  Google Scholar 

  15. Reine TM, Vuong TT, Jenssen TG, Kolset SO (2014) Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro. Biochim Biophys Acta Gen Subj 1840(8):2498–2505

    Article  CAS  Google Scholar 

  16. Berry RB, Brooks R, Gamaldo CE et al (2012) The AASM manual for the scoring of sleep and associated events. Rules, Terminology and Technical Specifications, Darien, Illinois, American Academy of Sleep Medicine

  17. Hatipoglu U, Rubinstein I (2003) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70(6):665–671. https://doi.org/10.1159/000075218

    Article  PubMed  Google Scholar 

  18. Torelli F, Moscufo N, Garreffa G et al (2011) Cognitive profile and brain morphological changes in obstructive sleep apnea. Neuroimage 54(2):787–793. https://doi.org/10.1016/j.neuroimage.2010.09.065

    Article  PubMed  Google Scholar 

  19. Bauters F, Rietzschel ER, Hertegonne KB, Chirinos JA (2016) The link between obstructive sleep apnea and cardiovascular disease. Curr Atheroscler Rep 18(1):1. https://doi.org/10.1007/s11883-015-0556-z

    Article  PubMed  Google Scholar 

  20. Ifergane G, Ovanyan A, Toledano R et al (2016) Obstructive sleep apnea in acute stroke: a role for systemic inflammation. Stroke 47(5):1207–1212. https://doi.org/10.1161/STROKEAHA.115.011749

    Article  CAS  PubMed  Google Scholar 

  21. Kanbay A, Kaya E, Büyükoğlan H et al (2015) Correlation between pentraxin-3 and endothelial dysfunction in obstructive sleep apnea syndrome. Ann Thorac Med 10(3):199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nacher M, Serrano-Mollar A, Farre R et al (2007) Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155(1):93–96. https://doi.org/10.1016/j.resp.2006.06.004

    Article  PubMed  Google Scholar 

  23. Sun H, Zhang H, Li K et al (2019) ESM-1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxia. J Cell Physiol 234(2):1512–1521

    Article  CAS  PubMed  Google Scholar 

  24. Scherpereel A, Depontieu F, Grigoriu B et al (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34(2):532–537. https://doi.org/10.1097/01.ccm.0000198525.82124.74

    Article  CAS  PubMed  Google Scholar 

  25. Malyszko J, Koc-Zorawska E, Malyszko JS (2018) Endocan concentration in kidney transplant recipients. Transplant Proc 50(6):1798–1801. https://doi.org/10.1016/j.transproceed.2018.02.123

    Article  CAS  PubMed  Google Scholar 

  26. El-Senosy FM, Abd El Aziz REM, Kasim SA et al (2022) Serum endocan levels and subclinical atherosclerosis in patients with chronic kidney and end-stage renal diseases. Int J Clin Pract 2022:4524637. https://doi.org/10.1155/2022/4524637

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yazan S, Karakurt H, Pusuroglu H (2023) Relationship between obstructive sleep apnea severity and serum endocan levels in patients with hypertension. Tex Heart Inst J 50(1). https://doi.org/10.14503/THIJ-21-7664

  28. Kum RO, Kundi FCS, Baklaci D et al (2018) Predicting severe sleep apnea in patients with complaints: pulse oximetry and body mass index. Turk Arch Otorhinolaryngol 56(3):149–154. https://doi.org/10.5152/tao.2018.2928

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kritikou I, Basta M, Tappouni R et al (2013) Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J 41(3):601–609. https://doi.org/10.1183/09031936.00183411

    Article  CAS  PubMed  Google Scholar 

  30. Woulfe DS, Lilliendahl JK, August S et al (2008) Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood 111(7):3458–3467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Schmidt RE, MacDermott RP, Bartley G et al (1985) Specific release of proteoglycans from human natural killer cells during target lysis. Nature 318(6043):289

    Article  CAS  PubMed  Google Scholar 

  32. Korpetinou A, Skandalis SS, Labropoulou VT et al (2014) Serglycin: at the crossroad of inflammation and malignancy. Front Oncol 3:327. https://doi.org/10.3389/fonc.2013.00327

    Article  PubMed  PubMed Central  Google Scholar 

  33. Meen AJ, Øynebråten I, Reine TM et al (2011) Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROα/CXCL1. J Biol Chem 286(4):2636–2647

    Article  CAS  PubMed  Google Scholar 

  34. Ilgın BU, Kızıltunç E, Gök M et al (2021) Association between serum serglycin levels and St-segment elevation myocardial infarction. Arq Bras Cardiol 116:756–762

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ohga E, Nagase T, Tomita T et al (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87(1):10–14

    Article  CAS  PubMed  Google Scholar 

  36. Ohga ETT, Wada H, Yamamoto H et al (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94(1):179–184

    Article  CAS  PubMed  Google Scholar 

  37. Woulfe DS, Lilliendahl JK, August S et al (2008) Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood 111(7):3458–3467. https://doi.org/10.1182/blood-2007-07-104703

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bolayir HA, Kivrak T, Gunes H et al (2018) The association between serum serglycin level and coronary artery disease severity in patients with stable angina pectoris. Kardiol Pol 76(4):783–790. https://doi.org/10.5603/KP.2018.0007

    Article  PubMed  Google Scholar 

  39. Doncheva AI, Norheim FA, Hjorth M et al (2022) Serglycin is involved in adipose tissue inflammation in obesity. J Immunol 208(1):121–132

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material and method preparation were performed by R.O.K., F.C.S.K., and C.T. Data collection and analysis were performed by R.O.K. and C.T. Statistical analysis and interpretation were performed by R.O.K. All the authors contributed to writing and read and approved the final version of the manuscript.

Corresponding author

Correspondence to Rauf Oguzhan Kum.

Ethics declarations

Ethical approval

Our study was approved by the local ethics committee and conducted in accordance with the ethical principles described by the Declaration of Helsinki (Project No. E16-933).

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kum, R.O., Sazak Kundi, F.C., Topcuoglu, C. et al. Investigation of serum endocan and serglycin levels in obstructive sleep apnea. Ir J Med Sci 192, 2909–2915 (2023). https://doi.org/10.1007/s11845-023-03360-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-023-03360-3

Keywords

Navigation